121 related articles for article (PubMed ID: 4804224)
1. [Biological behavior: serum levels, excretion and biotransformation of (3-benzoylphenyl)-2-propionic acid, or ketoprofen, in animals and men].
Populaire P; Terlain B; Pascal S; Decouvelaere B; Renard A; Thomas JP
Ann Pharm Fr; 1973 Dec; 31(12):735-49. PubMed ID: 4804224
[No Abstract] [Full Text] [Related]
2. [Absorption and excretion of ketoprofen: estimation of its blood concentration and urinary excretion in man following oral, rectal, or intramuscular administration].
Kageyama T; Sugawara S; Sato H
Ryumachi; 1973 Jul; 13(3):245-55. PubMed ID: 4755622
[No Abstract] [Full Text] [Related]
3. [Preliminary research on the pharmacokinetics of ketoprofen in man].
Castegnaro E; Iannotta F; Pollini C
Farmaco Prat; 1974 Sep; 29(9):520-2. PubMed ID: 4421824
[No Abstract] [Full Text] [Related]
4. [Determination of (benzoyl-3 phenyl)-2 propionic acid or ketoprofen in biological media].
Populaire P; Terlain B; Pascal S; Decouvelaere B; Lebreton G; Renard A; Thomas JP
Ann Pharm Fr; 1973 Nov; 31(11):679-89. PubMed ID: 4794314
[No Abstract] [Full Text] [Related]
5. Absorption, distribution, metabolism, and excretion of naproxen in various laboratory animals and human subjects.
Runkel R; Chaplin M; Boost G; Segre E; Forchielli E
J Pharm Sci; 1972 May; 61(5):703-8. PubMed ID: 4624708
[No Abstract] [Full Text] [Related]
6. Disposition and metabolism of fenbufen in several laboratory animals.
Chiccarelli FS; Eisner HJ; Van Lear GE
Arzneimittelforschung; 1980; 30(4A):707-15. PubMed ID: 6776965
[TBL] [Abstract][Full Text] [Related]
7. [Pharmacological study of ketoprofen (19583RP). Report No. 1. Anti-inflammatory, analgesic and antipyretic activities in oral administration].
Fujimura H; Tsurumi K; Hiramatsu Y; Go K; Nakano K
Nihon Yakurigaku Zasshi; 1974 Jul; 70(4):543-68. PubMed ID: 4475015
[No Abstract] [Full Text] [Related]
8. Naproxen oral absorption characteristics.
Runkel RA; Kraft KS; Boost G; Sevelius H; Forchielli E; Hill R; Magoun R; Szakacs JB; Segre E
Chem Pharm Bull (Tokyo); 1972 Jul; 20(7):1457-66. PubMed ID: 4640447
[No Abstract] [Full Text] [Related]
9. Absorption, excretion and metabolism of a new analgesic and anti-inflammatory drug K 4277 in rats, guinea pigs, rabbits and dogs.
Goldaniga GC; Pianezzola E; Valzelli G
Arzneimittelforschung; 1974 Oct; 24(10):1603-6. PubMed ID: 4479768
[No Abstract] [Full Text] [Related]
10. [Biotransformation and excretion of Z-2-amino-5-chlorobenzophenoneamidinohydrazone].
Borchert HH; Schieweck A; Franke P; Morgenroth U; Joram U
Pharmazie; 1993 May; 48(5):365-70. PubMed ID: 8327565
[TBL] [Abstract][Full Text] [Related]
11. Metabolism of N-oxide of 1-methyl-4-phenyl-4-piperidinol propionate in rabbits, rats and mice.
Chyczewski T
Pol J Pharmacol Pharm; 1973; 25(4):373-8. PubMed ID: 4774245
[No Abstract] [Full Text] [Related]
12. [Animal experiments on pharmacokinetics and biotransformation following administration of radioactive-labelled propiramfumarate].
Duhm B; Maul W; Medenwald H; Patzschke K; Wegner LA
Arzneimittelforschung; 1974 Apr; 24(4):632-43. PubMed ID: 4406933
[No Abstract] [Full Text] [Related]
13. Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes.
Kalgutkar AS; Hatch HL; Kosea F; Nguyen HT; Choo EF; McClure KF; Taylor TJ; Henne KR; Kuperman AV; Dombroski MA; Letavic MA
Biopharm Drug Dispos; 2006 Nov; 27(8):371-86. PubMed ID: 16944451
[TBL] [Abstract][Full Text] [Related]
14. Physiological disposition of fenoprofen in man. I. Pharmacokinetic comparison of calcium and sodium salts administered orally.
Rubin A; Rodda BE; Warrick P; Ridolfo A; Gruber CM
J Pharm Sci; 1971 Dec; 60(12):1797-801. PubMed ID: 5157992
[No Abstract] [Full Text] [Related]
15. [Pharmacokinetic studies on azapropazone in animals].
Jahn U; Reller J; Schatz F
Arzneimittelforschung; 1973 May; 23(5):660-6. PubMed ID: 4740207
[No Abstract] [Full Text] [Related]
16. Naproxen suppository: tissue response and comparative bioavailability.
Sevelius H; Runkel R; Pardo A; Ortega E; Varady J; Segre E
Eur J Clin Pharmacol; 1973 Jun; 6(1):22-5. PubMed ID: 4764370
[No Abstract] [Full Text] [Related]
17. Biochemical investigations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370). 1. Serum levels and urinary excretion in rats, rabbits and dogs.
Coppi G; Bonardi G; Perego R
Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:234-6. PubMed ID: 5067199
[No Abstract] [Full Text] [Related]
18. The pharmacokinetics and acceptability of benoxaprofen following rectal administration.
Jones RW; Waugh AE; Woodage TJ; Wild RN; Glynne A
J Rheumatol Suppl; 1980; 6():20-6. PubMed ID: 6930484
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic studies of benoxaprofen after therapeutic doses with a review of related pharmacokinetic and metabolic studies.
Nash JF; Carmichael RH; Ridolfo AS; Spradlin CT
J Rheumatol Suppl; 1980; 6():12-9. PubMed ID: 6930483
[TBL] [Abstract][Full Text] [Related]
20. Naproxen-aspirin interactions in man.
Segre EJ; Chaplin M; Forchielli E; Runkel R; Sevelius H
Clin Pharmacol Ther; 1974 Apr; 15(4):374-9. PubMed ID: 4821440
[No Abstract] [Full Text] [Related]
[Next] [New Search]
